Is 37LRP cell surface receptor for PSP94?
作者信息
Pathak Bhakti R, Jagtap Dhanshree D, Mahale Smita D
出版信息
Asian J Androl. 2011 Mar;13(2):347. doi: 10.1038/aja.2010.185. Epub 2011 Feb 7.
Abstract
摘要
相似文献
1
Is 37LRP cell surface receptor for PSP94?37LRP是PSP94的细胞表面受体吗？
Asian J Androl. 2011 Mar;13(2):347. doi: 10.1038/aja.2010.185. Epub 2011 Feb 7.
2
Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.37 kDa层粘连蛋白受体前体在抗转移的PSP94衍生肽PCK3145细胞表面结合中的作用。
Biochem Biophys Res Commun. 2006 Jul 21;346(1):358-66. doi: 10.1016/j.bbrc.2006.05.139. Epub 2006 Jun 2.
3
Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.假定的前列腺癌生物标志物PSP94和CRISP-3的生长抑制特性
Asian J Androl. 2011 Mar;13(2):205-6. doi: 10.1038/aja.2010.120. Epub 2010 Nov 22.
4
Structural and molecular biology of PSP94: Its significance in prostate pathophysiology.PSP94 的结构和分子生物学：在前列腺病理生理学中的意义。
Front Biosci (Landmark Ed). 2018 Jan 1;23(3):535-562. doi: 10.2741/4604.
5
Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.抗转移的PSP94衍生肽PCK3145对MMP-9分泌的抑制作用需要细胞表面层粘连蛋白受体信号传导。
Anticancer Drugs. 2006 Apr;17(4):429-38. doi: 10.1097/01.cad.0000203388.68034.06.
6
Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.PSP94 或 CRISP-3 介导的生长抑制具有前列腺癌细胞系特异性。
Asian J Androl. 2010 Sep;12(5):677-89. doi: 10.1038/aja.2010.56. Epub 2010 Aug 2.
7
Detection of PSP94 and its specific binding sites in the prostate adenocarcinoma cell line LNCaP.前列腺腺癌细胞系LNCaP中PSP94及其特异性结合位点的检测。
J Urol. 1998 Dec;160(6 Pt 1):2240-4. doi: 10.1097/00005392-199812010-00093.
8
Interactions of the 67 kDa laminin receptor and its precursor with laminin.67kDa 层粘连蛋白受体及其前体与层粘连蛋白的相互作用。
Biosci Rep. 2009 Nov 10;30(2):73-9. doi: 10.1042/BSR20090023.
9
The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor.含94个氨基酸残基的前列腺分泌蛋白（PSP94）作为前列腺肿瘤血清标志物的潜在用途。
Urol Res. 1993 May;21(3):227-33. doi: 10.1007/BF00590041.
10
PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer.PSP94是在卵巢癌中发现高度上调的前列腺素上游信号介质。
Cell Death Dis. 2014 Sep 4;5(9):e1407. doi: 10.1038/cddis.2014.374.
本文引用的文献
1
Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.假定的前列腺癌生物标志物PSP94和CRISP-3的生长抑制特性
Asian J Androl. 2011 Mar;13(2):205-6. doi: 10.1038/aja.2010.120. Epub 2010 Nov 22.
2
Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.37 kDa层粘连蛋白受体前体在抗转移的PSP94衍生肽PCK3145细胞表面结合中的作用。
Biochem Biophys Res Commun. 2006 Jul 21;346(1):358-66. doi: 10.1016/j.bbrc.2006.05.139. Epub 2006 Jun 2.
3
Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.抗转移的PSP94衍生肽PCK3145对MMP-9分泌的抑制作用需要细胞表面层粘连蛋白受体信号传导。
Anticancer Drugs. 2006 Apr;17(4):429-38. doi: 10.1097/01.cad.0000203388.68034.06.
4
A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis.一种源自前列腺分泌蛋白94的合成肽PCK3145可抑制内皮细胞中的血管内皮生长因子（VEGF）信号传导：对肿瘤血管生成的影响
Int J Cancer. 2006 May 1;118(9):2350-8. doi: 10.1002/ijc.21615.
5
Identification of binding proteins for PSP94 in human prostate adenocarcinoma cell lines LNCaP and PC-3.
Prostate. 1998 Apr 1;35(1):11-7. doi: 10.1002/(sici)1097-0045(19980401)35:1<11::aid-pros2>3.0.co;2-k.
6
Evidence for the presence of specific receptors for inhibin in human prostate.人前列腺中存在抑制素特异性受体的证据。
Indian J Exp Biol. 1982 May;20(5):419-20.
Zotero 插件